118 results
8-K
EX-10.1
BLUE
Bluebird bio Inc
3 May 24
Entry into a Material Definitive Agreement
7:00am
) during any period of twelve (12) consecutive months, a majority of the members of the Board of Directors of Company cease to be composed of individuals … was approved by individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of that Board
8-K
EX-99.2
BLUE
Bluebird bio Inc
8 Jan 24
Anticipate 85 to 105 patient starts (cell collections) across commercial portfolio in 2024 with first patient start for LYFGENIA expected in Q1 2024
8:03am
– Maintenance of VOE resolution in majority of patients through long-term follow up + stable production of HbAT87Q – 100% of patients with history of stroke (n … =5) remained free of recurrent stroke post- treatment with LYFGENIA – Majority of AEs attributed to underlying SCD or conditioning with busulfan
424B5
BLUE
Bluebird bio Inc
20 Dec 23
Prospectus supplement for primary offering
5:05pm
the majority of our cash and cash equivalents in accounts with major financial institutions, and our deposits at these institutions exceed insured limits … . As of November 30, 2023, we had 109,408,603 shares of common stock outstanding. A substantial majority of the outstanding shares of our common stock
8-K
EX-1.1
BLUE
Bluebird bio Inc
20 Dec 23
Entry into a Material Definitive Agreement
7:42am
, collaboration agreements or intellectual property license agreements) or any acquisition of assets or not less than a majority or controlling portion
424B5
BLUE
Bluebird bio Inc
18 Dec 23
Prospectus supplement for primary offering
5:07pm
to access the capital markets to meet liquidity needs. In addition, we maintain the majority of our cash and cash equivalents in accounts with major … outstanding. A substantial majority of the outstanding shares of our common stock are, and the shares of common stock sold in this offering upon issuance
8-K
EX-3.1
4vmaqdffwbt6 u8
18 Dec 23
Entry into a Material Definitive Agreement
4:48pm
8-K
EX-10.1
tv5hhu91
18 Dec 23
Entry into a Material Definitive Agreement
4:48pm
8-K
wx5m5jdmsu9lbnvkht
11 Dec 23
Regulation FD Disclosure
8:06am
8-K
EX-99.1
vt6jd1t
11 Dec 23
Regulation FD Disclosure
8:06am
8-K
EX-1.1
xz0v869ufkk fsha6skf
8 Aug 23
Entry into a Material Definitive Agreement
9:05am
424B5
suh4c ayw1kdoyr
8 Aug 23
Prospectus supplement for primary offering
9:03am
8-K
EX-99.1
espelnzz4w9b3
8 Aug 23
Regulation FD Disclosure
8:55am
8-K
EX-99.1
4xnk pj6d
12 Jul 23
Regulation FD Disclosure
12:00am
S-8
EX-99.1
rfils
16 Jun 23
Registration of securities for employees
4:03pm
8-K
EX-99.1
s00s1ukdh
12 Jun 23
Regulation FD Disclosure
7:28am
S-3
gbk 20wc3ldhksdib631
9 May 23
Shelf registration
4:28pm
S-3
EX-4.3
an5gb03zuqekbjk99a1
9 May 23
Shelf registration
4:28pm